About NanoEntek
NanoEntek is a publicly listed company based in Seoul (South Korea) founded in 2000. Point-of-care instruments for diagnostics and research are developed. It operates in the Healthcare and Technology sectors. The company has 138 employees. Its website nanoentek.com draws about 14 thousand monthly visits. NanoEntek offers products and services including FREND™ System, EVE™ HT FL, ADAM™ MC Plus, ADAM™ rWBC HT, and ADAMII™. Its focus areas include High Tech, Nanotechnology, Nanoenabled Products and Life Science.
Company details
NanoEntek was founded in 2000 in Seoul, South Korea, where point-of-care instruments for in vitro diagnostics and life science research are developed. Proprietary MEMS fabrication technologies are utilized in flagship products. Automated immunoassay solutions like FREND and BUDDI, ADAM for rWBC counting, and the JULI series for cell counting are offered. Reagents and kits for oncology and infectious diseases are provided alongside these instruments.
- Headquarters Seoul, South Korea
- Employees 138
- Stage Public
- SectorsHealthcareTechnology
- Website category Health · Biotechnology and Pharmaceuticals
- Website nanoentek.com
- Social LinkedIn Facebook Instagram YouTube
- Legal Name Nanoentek, Inc.
- Annual Revenue$26.4 M (USD)25.16as on Dec 31, 2025
- Net Profit$1.09 M (USD)-55.93as on Dec 31, 2025
- EBITDA$3.13 M (USD)37.76as on Dec 31, 2025
- Latest Funding Round$8.43M (USD), Post-IPO
Aug 2015
- Employee Count138
Products & Services of NanoEntek
NanoEntek offers a comprehensive portfolio of products and services, including FREND™ System, EVE™ HT FL, ADAM™ MC Plus, ADAM™ rWBC HT, and ADAMII™.
Device for rapid microfluidic immunofluorescence analysis.
High-throughput fluorescence cell counting tool.
Accurate fluorescence-based cell counting device.
Counter for residual white blood cell detection.
Fluorescence counter for CD34 cell analysis.
Apps and channels of NanoEntek
its YouTube channel NanoEntek 나노엔텍 has 365 subscribers and 30 videos.
Videos from NanoEntek
The most watched videos on NanoEntek's YouTube channel, NanoEntek 나노엔텍 (365 subscribers). Click a video to play it here.
More on NanoEntek 나노엔텍.
Funding Insights of NanoEntek
- Total Rounds 1
- Last Round Post-IPO — $8.43M
- First Round $8.43M
(Aug 2015)
All 1 funding rounds of NanoEntek with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2015 | $8.43M | Post-IPO | – | – | – |
People of NanoEntek
5 people are tracked at NanoEntek (3 in leadership, 2 in team); the tracked headcount is 138.
| Name | Role | Group |
|---|---|---|
Chanil Chung | CEO | Leadership |
Sean Kim | 본부장, Sr. Director Of Global Sales | Leadership |
Jun Young Seo | Chief Financial Officer | Leadership |
Ashley Jamison | Western U.s. Territory Manager - Life Science | Team |
Mino Kang | Manager | Team |
Complete people profiles for NanoEntek
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of NanoEntek
NanoEntek is a publicly listed company on the KRX with ticker symbol 039860 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date15 Oct 2010
- Listed onKRX: 039860
- Listed entityNanoenTek, Inc.
- Exchange sectorHealth technology
- ISINKR7039860002
- Share price4,290.00 KRW (-0.69% on the day) · 2026-10-14
- Market capitalisation164,562,000,732.00 KRW
- Price to earnings26.2
- EPS (diluted, trailing year)163.63 KRW
- Volume (last session)120,324
Financials of NanoEntek
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 38.13B KRW | 1.58B KRW | 4.52B KRW |
| 2024 | 30.46B KRW | 3.59B KRW | 3.28B KRW |
| 2023 | 26.84B KRW | -3.68B KRW | 319.0M KRW |
| 2022 | 35.20B KRW | 4.66B KRW | 6.82B KRW |
| 2021 | 35.78B KRW | 7.32B KRW | 7.89B KRW |
Detailed financial statements for NanoEntek
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of NanoEntek
3 dated milestones of NanoEntek across 15 years, from founding to its latest funding, stage changes and deals.
- Founded NanoEntek is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $8.4M.
Web traffic of NanoEntek
The website of NanoEntek (nanoentek.com) receives about 13.6K visits a month and ranks #1,579,171 among all websites worldwide, #2,113 in Biotechnology and Pharmaceuticals.
- Monthly visits13.6K
▼ 11.4% vs previous month
- Unique visitors7.4K
per month
- Global rank#1,579,171
among all websites
- Category rank#2,113
Health · Biotechnology and Pharmaceuticals
- Bounce rate47%
- Pages per visit1.9
- Average visit29 sec
- DevicesDesktop 29% · Mobile 71%
Websites whose visitors overlap most with NanoEntek. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| meta-biomed.com | 100% | 12.9K | #2,073,314 | View details | |
| solco.co.kr | 61% | View details | |||
laxtha.com | laxtha.com | 60% | #3,257,407 | – | |
inbody.com | inbody.com | 60% | #73,580 | – | |
| flukebiomedical.com | 60% | #700,084 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for NanoEntek
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nanoentek
Complete news archive for NanoEntek
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NanoEntek
NanoEntek was founded in 2000 and raised its 1st funding round 15 years after it was founded.
NanoEntek is headquartered in Seoul, South Korea.
NanoEntek has 138 employees.
Annual revenue of NanoEntek is $26.4M as on Dec 31, 2025.
NanoEntek was founded in 2000 in Seoul, South Korea, where point-of-care instruments for in vitro diagnostics and life science research are developed. Proprietary MEMS fabrication technologies are utilized in flagship products. Automated immunoassay solutions like FREND and BUDDI, ADAM for rWBC counting, and the JULI series for cell counting are offered. Reagents and kits for oncology and infectious diseases are provided alongside these instruments.
NanoEntek offers FREND™ System, EVE™ HT FL, ADAM™ MC Plus, ADAM™ rWBC HT, and ADAMII™.
Yes, NanoEntek is publicly traded on KRX under the ticker symbol 039860.